Cargando…

A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI

PURPOSE: Liver imaging reporting and data system (LI-RADS) classification, especially the identification of LR-3 to 5 lesions with hepatocellular carcinoma (HCC) probability, is of great significance to treatment strategy determination. We aimed to develop a semi-automatic LI-RADS grading system on...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Ruofan, Huang, Jing, Zhang, Weiguo, Jin, Kaipu, Yang, Li, Chong, Huanhuan, Fan, Jia, Zhou, Jian, Wu, Dijia, Zeng, Mengsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255313/
https://www.ncbi.nlm.nih.gov/pubmed/34235105
http://dx.doi.org/10.2147/JHC.S316385
_version_ 1783717879897653248
author Sheng, Ruofan
Huang, Jing
Zhang, Weiguo
Jin, Kaipu
Yang, Li
Chong, Huanhuan
Fan, Jia
Zhou, Jian
Wu, Dijia
Zeng, Mengsu
author_facet Sheng, Ruofan
Huang, Jing
Zhang, Weiguo
Jin, Kaipu
Yang, Li
Chong, Huanhuan
Fan, Jia
Zhou, Jian
Wu, Dijia
Zeng, Mengsu
author_sort Sheng, Ruofan
collection PubMed
description PURPOSE: Liver imaging reporting and data system (LI-RADS) classification, especially the identification of LR-3 to 5 lesions with hepatocellular carcinoma (HCC) probability, is of great significance to treatment strategy determination. We aimed to develop a semi-automatic LI-RADS grading system on multiphase gadoxetic acid-enhanced MRI using deep convolutional neural networks (CNN). PATIENTS AND METHODS: An internal data set of 439 patients and external data set of 71 patients with suspected HCC were included and underwent gadoxetic acid-enhanced MRI. The expert-guided LI-RADS grading system consisted of four deep 3D CNN models including a tumor segmentation model for automatic diameter estimation and three classification models of LI-RADS major features including arterial phase hyper-enhancement (APHE), washout and enhancing capsule. An end-to-end learning system comprising single deep CNN model that directly classified the LI-RADS grade was developed for comparison. RESULTS: On internal testing set, the segmentation model reached a mean dice of 0.84, with the accuracy of mapped diameter intervals as 82.7% (95% CI: 74.4%, 91.7%). The area under the curves (AUCs) were 0.941 (95% CI: 0.914, 0.961), 0.859 (95% CI: 0.823, 0.890) and 0.712 (95% CI: 0.668, 0.754) for APHE, washout and capsule, respectively. The expert-guided system significantly outperformed the end-to-end system with a LI-RADS grading accuracy of 68.3% (95% CI: 60.8%, 76.5%) vs 55.6% (95% CI: 48.8%, 63.0%) (P<0.0001). On external testing set, the accuracy of mapped diameter intervals was 91.5% (95% CI: 81.9%, 100.0%). The AUCs were 0.792 (95% CI: 0.745, 0.833), 0.654 (95% CI: 0.602, 0.703) and 0.658 (95% CI: 0.606, 0.707) for APHE, washout and capsule, respectively. The expert-guided system achieved an overall grading accuracy of 66.2% (95% CI: 58.0%, 75.2%), significantly higher than the end-to-end system of 50.1% (95% CI: 43.1%, 58.1%) (P<0.0001). CONCLUSION: We developed a semi-automatic step-by-step expert-guided LI-RADS grading system (LR-3 to 5), superior to the conventional end-to-end learning system. This deep learning-based system may improve workflow efficiency for HCC diagnosis in clinical practice.
format Online
Article
Text
id pubmed-8255313
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-82553132021-07-06 A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI Sheng, Ruofan Huang, Jing Zhang, Weiguo Jin, Kaipu Yang, Li Chong, Huanhuan Fan, Jia Zhou, Jian Wu, Dijia Zeng, Mengsu J Hepatocell Carcinoma Original Research PURPOSE: Liver imaging reporting and data system (LI-RADS) classification, especially the identification of LR-3 to 5 lesions with hepatocellular carcinoma (HCC) probability, is of great significance to treatment strategy determination. We aimed to develop a semi-automatic LI-RADS grading system on multiphase gadoxetic acid-enhanced MRI using deep convolutional neural networks (CNN). PATIENTS AND METHODS: An internal data set of 439 patients and external data set of 71 patients with suspected HCC were included and underwent gadoxetic acid-enhanced MRI. The expert-guided LI-RADS grading system consisted of four deep 3D CNN models including a tumor segmentation model for automatic diameter estimation and three classification models of LI-RADS major features including arterial phase hyper-enhancement (APHE), washout and enhancing capsule. An end-to-end learning system comprising single deep CNN model that directly classified the LI-RADS grade was developed for comparison. RESULTS: On internal testing set, the segmentation model reached a mean dice of 0.84, with the accuracy of mapped diameter intervals as 82.7% (95% CI: 74.4%, 91.7%). The area under the curves (AUCs) were 0.941 (95% CI: 0.914, 0.961), 0.859 (95% CI: 0.823, 0.890) and 0.712 (95% CI: 0.668, 0.754) for APHE, washout and capsule, respectively. The expert-guided system significantly outperformed the end-to-end system with a LI-RADS grading accuracy of 68.3% (95% CI: 60.8%, 76.5%) vs 55.6% (95% CI: 48.8%, 63.0%) (P<0.0001). On external testing set, the accuracy of mapped diameter intervals was 91.5% (95% CI: 81.9%, 100.0%). The AUCs were 0.792 (95% CI: 0.745, 0.833), 0.654 (95% CI: 0.602, 0.703) and 0.658 (95% CI: 0.606, 0.707) for APHE, washout and capsule, respectively. The expert-guided system achieved an overall grading accuracy of 66.2% (95% CI: 58.0%, 75.2%), significantly higher than the end-to-end system of 50.1% (95% CI: 43.1%, 58.1%) (P<0.0001). CONCLUSION: We developed a semi-automatic step-by-step expert-guided LI-RADS grading system (LR-3 to 5), superior to the conventional end-to-end learning system. This deep learning-based system may improve workflow efficiency for HCC diagnosis in clinical practice. Dove 2021-06-29 /pmc/articles/PMC8255313/ /pubmed/34235105 http://dx.doi.org/10.2147/JHC.S316385 Text en © 2021 Sheng et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Sheng, Ruofan
Huang, Jing
Zhang, Weiguo
Jin, Kaipu
Yang, Li
Chong, Huanhuan
Fan, Jia
Zhou, Jian
Wu, Dijia
Zeng, Mengsu
A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI
title A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI
title_full A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI
title_fullStr A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI
title_full_unstemmed A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI
title_short A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI
title_sort semi-automatic step-by-step expert-guided li-rads grading system based on gadoxetic acid-enhanced mri
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255313/
https://www.ncbi.nlm.nih.gov/pubmed/34235105
http://dx.doi.org/10.2147/JHC.S316385
work_keys_str_mv AT shengruofan asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT huangjing asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT zhangweiguo asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT jinkaipu asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT yangli asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT chonghuanhuan asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT fanjia asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT zhoujian asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT wudijia asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT zengmengsu asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT shengruofan semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT huangjing semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT zhangweiguo semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT jinkaipu semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT yangli semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT chonghuanhuan semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT fanjia semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT zhoujian semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT wudijia semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri
AT zengmengsu semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri